Biogen Inc (BIIB)

Biogen Inc (BIIB) is a Drug Manufacturers - General company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $37B; returns 1 day -1.2%, 1 week +7.8%, 1 year +67.0%.

Biogen Inc. is a biotechnology company primarily focused on discovering, developing, manufacturing, and delivering therapies for neurological and neurodegenerative diseases.

Groups BIIB belongs to

• Biotechnology
• S&P 500
• Neuroscience
• Neurological Disorders
• Pharmaceuticals
• Commercial Stage Biotech
• Alzheimer's Disease
• Healthcare
• Rare Diseases
• Life Sciences
• Biologics

BIIB financial model: income statement, cash flow and balance sheet